TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group

Eur J Cancer Clin Oncol. 1989 Dec;25(12):1889-90. doi: 10.1016/0277-5379(89)90365-9.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Taurine / adverse effects
  • Taurine / analogs & derivatives*
  • Taurine / therapeutic use

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Taurine
  • 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea